Logo

Evotec Collaborates with Vifor Pharma to Launch a Joint Venture to Discover and Develop Therapies for Nephrology

Share this

Evotec Collaborates with Vifor Pharma to Launch a Joint Venture to Discover and Develop Therapies for Nephrology

Shots:

  • Evotec to apply its drug discovery & development capabilities plus will utilize Vifor Pharma’s platform for creating pipeline of nephrology program and with the completion of clinical trials evaluating products Vifor Pharma will in-license them for registration and commercialization while expanding its nephrology pipeline
  • Vifor to fund €25M for pre-clinical development while the companies will be sharing all the clinical and commercial costs on successful candidates with opt-out rights at each stage based on a predetermined profit share arrangement
  • The agreement will involve the combination of Evotec’s drug discovery capabilities with Vifor Pharma’s development and commercialization expertise in Nephrology and will focus on patient data-driven target identification pursing medication for treating kidney disorders

Click here to­ read full press release/ article | Ref: Evotec | Image: Forbes


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions